Skip to content

Cannabis: all studies

Page 5 of 287: studies 41 to 50 of 2,868, newest first. Back to the cannabis overview

Research

Trends in Cannabis Exposure and Psychosis Among U.S. Adolescents in Emergency Rooms from 2016 to 2024

Journal of addiction psychiatry August 14, 2026 Sue D. Muggar, Jaime A. Perez, F. Laviolette et al.

Objectives: To utilize a retrospective observational design to characterize adolescents aged 13 - 17 presenting to emergency rooms (ER) in the United States (US) from 2016 to 2024 with psychosis and/or delta-9-tetrahydrocannabinol (THC) exposure via urine drug screens (UDS) and to evaluate trends in THC exposure, psychiatric comorbidities, and demographics. Material and Methods: De-identified,...

A six-hour time series of the acute effects of ingested cannabis intoxication on a battery of cognitive-motor tasks

PLoS One August 13, 2026 Paige Copeland, Quinn Malone, Brian H. Dalton et al.

The psychoactive component of cannabis, Δ9-tetrahydrocannabinol (THC), is known to alter cognitive-motor function; however, despite the high prevalence of cannabis use globally, the time course of the effects of ingesting THC is unclear. To allow future studies to accurately time the assessment of the impacts of cannabis on behaviour, this study aimed to establish a detailed time series of...

A contemporary exploration of motivations and practices of psychedelic use among emerging adult cannabis users in the United States: A qualitative analysis.

Psychology of Addictive Behaviors August 13, 2026 Bridgid M Conn, Alisha Osornio, Kaia Sheean et al.

Despite increased naturalistic psychedelic use in the United States, limited studies explore factors currently contributing to use among ethnically and racially diverse psychedelic and cannabis-using adults. This study employs thematic analysis using qualitative data to explore the factors contributing to contemporary psychedelic use. Qualitative interviews (conducted in 2022-2023) from a...

Investigating sex differences in the acute effects of smoked cannabis: a potency-ranging, controlled administration, human laboratory experiment.

Psychopharmacology August 11, 2026 Madison Wright, Justin Matheson, Adam Zaweel et al.

RATIONALE Sex differences in the effects of cannabis have been demonstrated in animals, though the human evidence is more equivocal. In particular, more work is needed to better understand interactions between sex and dose in determining acute pharmacological effects of cannabis, especially at higher potencies of Δ9-tetrahydrocannabinol (THC). OBJECTIVES Sex differences were examined following...

THC and CBD differentially modulated gut microbiota in the Poly I:C rat model of schizophrenia

Frontiers in Pharmacology August 10, 2026 N. Miguel-Ramiro, N. Lamanna-Rama, M. Casquero-Veiga et al.

Background Disruptions in the gut-brain-microbiota axis are increasingly linked to psychiatric disorders. While cannabinoids possess immunomodulatory and neuroprotective properties, their impact on the microbial architecture during critical neurodevelopmental periods remains poorly understood. This exploratory study investigated whether adolescent treatment with delta-9-tetrahydrocannabinol...

Cannabis use preceded early‐onset psychosis and was associated with worse outcomes

Alcoholism & Drug Abuse Weekly August 10, 2026 Alison Knopf

Cannabis use and cannabis use disorder (CUD) are common in early‐onset psychosis. Clinical presentation is key when determining which is present and which to treat first. But reducing cannabis use would help. A study published in the Journal of the American Academy of Child and Adolescent Psychiatry found that cannabis use preceded the psychosis symptoms. Researchers found that screening and...

Δ9-Tetrahydrocannabinol Modulates Hippocampal Neurogenesis in Female Wistar Rats: Interaction with Estradiol.

Neurochemical Research August 8, 2026 Duarte R Carvalhinho, Sandra I Marques, Sandra Leal et al.

The endocannabinoid system (ECS) plays a key role in regulating neurogenesis and inflammatory processes in the brain. The increasing prevalence of Cannabis use among women highlights the importance of understanding sex-specific effects of cannabinoids, particularly in the context of hormonal interactions. This study aimed to investigate the effects of delta-9-tetrahydrocannabinol (THC) and...

Exploring The Cannabis Use Behaviours of Individuals with Clinically and Self-diagnosed ADHD in New Zealand

Otago University Research Archive August 4, 2026 Caitlin Elaine Thorburn

While cannabis has been reported to have many therapeutic utilisations, minimal studies have explored the use behaviours of individuals with ADHD in New Zealand. Due to the considerably high rates of cannabis use within this population, it is necessary that this gap in the literature is explored. Of the analyses that have been conducted, it appears that the self-medication hypothesis may...

Mind-manifesting? Examining naturalistic reports from psychedelics, cannabis, meditation, and dreams from the ALTERD mobile application

bioRxiv (Cold Spring Harbor Laboratory) August 4, 2026 Conor H. Murray, Michael Angyus, Sam Suchin et al. preprint

Abstract Altered states of consciousness (ASC) refer to states that differ markedly from normal waking consciousness. ASC may occur spontaneously, such as in dreaming, or through consciousness modifying techniques, from meditation, to cannabis and psychedelics. The etymology behind the term psychedelic, meaning mind-manifesting, is based on the hypothesis that certain substances, including...

Chronic THC exposure modulates behavioral outcomes and endocannabinoid signaling in HIV-1 Tg26 mice in a sex-dependent manner.

Brain Research Bulletin August 1, 2026 Barkha J. Yadav-Samudrala, Laith E. Sawaqed, Caitlin J. Huguely Wilkinson et al.

While combined antiretroviral therapy (cART) has transitioned HIV-1 into a manageable chronic condition, it fails to eradicate latent viral reservoirs in the central nervous system (CNS) that drive persistent neuroinflammation and synaptodendritic injury. Consequently, people living with human immunodeficiency virus type-1 (HIV-1) often utilize cannabis to manage neurological symptoms, yet the...